NANOSONICS LIMITED — Director's Dealing 2016

Jan 3, 2016

==> picture [204 x 82] intentionally omitted <==

4 January 2016

Company Announcements Office Australian Securities Exchange

Appendix 3Y Change of Director’s Interest Notice

Attached are Appendix 3Y- Change of Director’s Interest Notices in respect of changes in the relevant interests in securities held by Directors Mr Michael Kavanagh and Dr Ron Weinberger reflecting the issue of Performance Rights under the Nanosonics Employee Share Option Plan in respect of the Company’s Long Term Incentive Scheme.

Nanosonics Limited

McGregor Grant Company Secretary

Nanosonics Limited ABN 11 095 076 896 14 Mars Road, Lane Cove, NSW 2066 Australia Tel: +61 2 8063 1600 Fax: +61 2 9317 5010 Email: info@nanosonics.com.au w: www.nanosonics.com.au

Appendix 3Y Change of Director’s Interest Notice

Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/09/01 Amended 01/01/11

Name of entity		Nanosonics Limited
ABN	11	095 076 896

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

We (the entity) give ASX the following the director for the purposes of section	information under listing rule 3.19A.2 and as agent for 205G of the Corporations Act.
Name of Director	Mr Michael Kavanagh
Date of last notice	13 November 2015

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Direct or indirect interest	a) Indirect Interest b) Indirect Interest c) Direct Interest
Nature of indirect interest (including registered holder) Note: Provide details of the circumstances giving rise to the relevant interest.	a) Performance Rights held in the Nanosonics Employee Share Option Plan. b) Shares held under the Nanosonics Deferred Employee Share Plan (Trust)
Date of change	4 January 2016
No. of securities held prior to change	a) 1,548,061 Performance Rights held in the Nanosonics Employee Share Option Plan b) 70,479 (indirect) Ordinary Shares c) 150,000 (Direct) Ordinary Shares

• See chapter 19 for defined terms.

01/01/2011 Appendix 3Y Page 1

Appendix 3Y Change of Director’s Interest Notice

Class	a) Performance Rights b) Ordinary Shares c) Ordinary Shares
Number acquired	a) 206,882 Performance Rights
Number disposed	NIL
Value/Consideration Note: If consideration is non-cash, provide details and estimated valuation	N/A
No. of securities held after change	a) 1,754,943 Performance Rights held in the Nanosonics Employee Share Option Plan. b) 70,479(Indirect) Ordinary Shares c) 150,000 (Direct) Ordinary Shares
Nature of change Example: on-market trade, off-market trade, exercise of options, issue of securities under dividend reinvestment plan, participation in buy-back	Issue of 206,882 Performance Rights under the terms and conditions of the Nanosonics Employee Share Option Plan.

Part 2 – Change of director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

Detail of contract	N/A
Nature of interest
Name of registered holder (if issued securities)
Date of change

• See chapter 19 for defined terms.

Appendix 3Y Page 2

01/01/2011

Appendix 3Y Change of Director’s Interest Notice

No. and class of securities to which interest related prior to change Note: Details are only required for a contract in relation to which the interest has changed Interest acquired Interest disposed Value/Consideration Note: If consideration is non-cash, provide details and an estimated valuation Interest after change

Part 3 –[+] Closed period

Were the interests in the securities or contracts detailed above traded during a[+] closed period where prior written clearance was required? If so, was prior written clearance provided to allow the trade to proceed during this period? If prior written clearance was provided, on what date was this provided?

Director: Mr. Michael Kavanagh Date: 4 January 2016

• See chapter 19 for defined terms.

01/01/2011 Appendix 3Y Page 3

Appendix 3Y Change of Director’s Interest Notice

Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/09/01 Amended 01/01/11

Name of entity	Nanosonics Limited
ABN	11 095 076 896

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

We (the entity) give ASX the following the director for the purposes of section	information under listing rule 3.19A.2 and as agent for 205G of the Corporations Act.
Name of Director	Dr Ronald Peter Weinberger
Date of last notice	13 November 2015

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Direct or indirect interest	a) Indirect Interest b) Indirect Interest c) Direct Interest
Nature of indirect interest (including registered holder) Note: Provide details of the circumstances giving rise to the relevant interest.	a) Performance Rights held in the Nanosonics Employee Share Option Plan b) Shares held under the Nanosonics Deferred Employee Share Plan
Date of change	4 January 2016
No. of securities held prior to change	a) 262,570 Performance Rights held in the Nanosonics Employee Share Option Plan b) 52,994 (Indirect) Ordinary Shares held in the Nanosonics Deferred Employee Share Plan c) 52,000 (Direct) Ordinary Shares

• See chapter 19 for defined terms.

01/01/2011 Appendix 3Y Page 1

Appendix 3Y Change of Director’s Interest Notice

Class	a) Performance Rights b) Ordinary Shares c) Ordinary Shares
Number acquired	70,992 Performance Rights
Number disposed	NIL
Value/Consideration Note: If consideration is non-cash, provide details and estimated valuation	N/A
No. of securities held after change	a) 333,562 Performance Rights held in the Nanosonics Employee Share Option Plan. b) Nil (Indirect) Ordinary Shares c) 104,994(Direct) Ordinary Shares
Nature of change Example: on-market trade, off-market trade, exercise of options, issue of securities under dividend reinvestment plan, participation in buy-back	Issue of 70,992 Performance Rights under the terms and conditions of the Nanosonics Employee Share Option Plan

Part 2 – Change of director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

Detail of contract	N/A
Nature of interest
Name of registered holder (if issued securities)
Date of change

• See chapter 19 for defined terms.

Appendix 3Y Page 2

01/01/2011

Appendix 3Y Change of Director’s Interest Notice

No. and class of securities to which interest related prior to change Note: Details are only required for a contract in relation to which the interest has changed Interest acquired Interest disposed Value/Consideration Note: If consideration is non-cash, provide details and an estimated valuation Interest after change

Part 3 –[+] Closed period

Were the interests in the securities or contracts detailed above traded during a[+] closed period where prior written clearance was required? If so, was prior written clearance provided to allow the trade to proceed during this period? If prior written clearance was provided, on what date was this provided?

Director: Dr Ronald Weinberger Date: 4 January 2016

• See chapter 19 for defined terms.

01/01/2011 Appendix 3Y Page 3